product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Anti-rat IgG (H+L), (Alexa Fluor 555 Conjugate)
catalog :
4417
conjugate :
nonconjugated
citations: 3
Reference
Lee R, Vazquez G. Reduced size and macrophage content of advanced atherosclerotic lesions in mice with bone marrow specific deficiency of alpha 7 nicotinic acetylcholine receptor. PLoS ONE. 2015;10:e0124584 pubmed publisher
Huang L, Zhang S, Zhang P, Zhang X, Zhu L, Chen K, et al. Interferon regulatory factor 7 protects against vascular smooth muscle cell proliferation and neointima formation. J Am Heart Assoc. 2014;3:e001309 pubmed publisher
Hammond S, Byrum S, Namjoshi S, Graves H, Dennehey B, Tackett A, et al. Mitotic phosphorylation of histone H3 threonine 80. Cell Cycle. 2014;13:440-52 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.